Amgen CEO Decries Federal Deliberations
Robert Bradway, chief government of Thousand Oaks pharma big Amgen Inc., has grown more and more pissed off on the authorities’s unwillingness to come back to phrases with Amgen over its $27.8 billion acquisition deal of Irish pharma firm Horizon Therapeutics. That deal, introduced final December, hit a significant stumbling block in Might when the … [Read more…]